Drug safety

Keyphrases

Publications

2023

Diego F Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernandez-Diaz
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug safety (2023)
Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Chiara Pugliese, Mattia Bartolucci, Elena Narmine Necibi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti, Elisabetta Poluzzi
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug safety (2023)
Comfort Kunak Ogar, Jonathan Quick, Hannah N Gilbert, Rick A Vreman, Aukje K Mantel-Teeuwisse, Jean Claude Mugunga
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study. Drug safety (2023)
John van Stekelenborg, Vijay Kara, Roman Haack, Ulrich Vogel, Anju Garg, Markus Krupp, Kate Gofman, Brian Dreyfus, Manfred Hauben, Andrew Bate
Correction to: Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks. Drug safety (2023)
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency. Drug safety (2023)
Comfort Kunak Ogar, Jonathan Quick, Hannah N Gilbert, Rick A Vreman, Aukje K Mantel-Teeuwisse, Jean Claude Mugunga
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study. Drug safety (2023)
Shuang Wang, Kimford J Meador, Jayne Pawasauskas, Adam K Lewkowitz, Kristina E Ward, Todd N Brothers, Abraham Hartzema, Brian J Quilliam, Xuerong Wen
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug safety (2023)
Diego F Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernandez-Diaz
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug safety (2023)

volume 46, number 2, 2023

Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)

volume 46, number 3, 2023

Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Chiara Pugliese, Mattia Bartolucci, Elena Narmine Necibi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti, Elisabetta Poluzzi
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug safety 46 (3) (2023)
Jillian H Hurst, Amanda Brucker, Congwen Zhao, Hannah Driscoll, Haley P Hostetler, Michael Phillips, Bari Rosenberg, Marc D Samsky, Isaac Smith, Megan E Reller, John J Strouse, Cindy Ke Zhou, Graça M Dores, Hui-Lee Wong, Benjamin A Goldstein
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug safety 46 (3) (2023)
Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans L Hillege, Peter G M Mol
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study. Drug safety 46 (3) (2023)
Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Chiara Pugliese, Mattia Bartolucci, Elena Narmine Necibi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti, Elisabetta Poluzzi
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug safety 46 (3) (2023)
Shuang Wang, Kimford J Meador, Jayne Pawasauskas, Adam K Lewkowitz, Kristina E Ward, Todd N Brothers, Abraham Hartzema, Brian J Quilliam, Xuerong Wen
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug safety 46 (3) (2023)
Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans L Hillege, Peter G M Mol
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study. Drug safety 46 (3) (2023)
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency. Drug safety 46 (3) (2023)
Jillian H Hurst, Amanda Brucker, Congwen Zhao, Hannah Driscoll, Haley P Hostetler, Michael Phillips, Bari Rosenberg, Marc D Samsky, Isaac Smith, Megan E Reller, John J Strouse, Cindy Ke Zhou, Graça M Dores, Hui-Lee Wong, Benjamin A Goldstein
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug safety 46 (3) (2023)
Shuang Wang, Kimford J Meador, Jayne Pawasauskas, Adam K Lewkowitz, Kristina E Ward, Todd N Brothers, Abraham Hartzema, Brian J Quilliam, Xuerong Wen
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug safety 46 (3) (2023)
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency. Drug safety 46 (3) (2023)
Diego F Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernandez-Diaz
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug safety 46 (3) (2023)
Jillian H Hurst, Amanda Brucker, Congwen Zhao, Hannah Driscoll, Haley P Hostetler, Michael Phillips, Bari Rosenberg, Marc D Samsky, Isaac Smith, Megan E Reller, John J Strouse, Cindy Ke Zhou, Graça M Dores, Hui-Lee Wong, Benjamin A Goldstein
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug safety 46 (3) (2023)
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency. Drug safety 46 (3) (2023)
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency. Drug safety 46 (3) (2023)
Shuang Wang, Kimford J Meador, Jayne Pawasauskas, Adam K Lewkowitz, Kristina E Ward, Todd N Brothers, Abraham Hartzema, Brian J Quilliam, Xuerong Wen
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug safety 46 (3) (2023)
Jillian H Hurst, Amanda Brucker, Congwen Zhao, Hannah Driscoll, Haley P Hostetler, Michael Phillips, Bari Rosenberg, Marc D Samsky, Isaac Smith, Megan E Reller, John J Strouse, Cindy Ke Zhou, Graça M Dores, Hui-Lee Wong, Benjamin A Goldstein
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug safety 46 (3) (2023)
Diego F Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernandez-Diaz
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug safety 46 (3) (2023)
Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans L Hillege, Peter G M Mol
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study. Drug safety 46 (3) (2023)
Diego F Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernandez-Diaz
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug safety 46 (3) (2023)
Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Chiara Pugliese, Mattia Bartolucci, Elena Narmine Necibi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti, Elisabetta Poluzzi
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug safety 46 (3) (2023)
Diego F Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernandez-Diaz
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug safety 46 (3) (2023)
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency. Drug safety 46 (3) (2023)
Shuang Wang, Kimford J Meador, Jayne Pawasauskas, Adam K Lewkowitz, Kristina E Ward, Todd N Brothers, Abraham Hartzema, Brian J Quilliam, Xuerong Wen
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug safety 46 (3) (2023)
Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans L Hillege, Peter G M Mol
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study. Drug safety 46 (3) (2023)
Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans L Hillege, Peter G M Mol
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study. Drug safety 46 (3) (2023)
Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Chiara Pugliese, Mattia Bartolucci, Elena Narmine Necibi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti, Elisabetta Poluzzi
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug safety 46 (3) (2023)
Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, Liana Gross-Martirosyan, Priya Bahri, Hans L Hillege, Peter G M Mol
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study. Drug safety 46 (3) (2023)

volume 46, number 5, 2023

Katarina Kralova, Carol-Ann Wilson, Nicolas Richebourg, Joan D'souza
Quality of MedDRA ® Coding in a Sample of COVID-19 Vaccine Medication Error Data. Drug safety 46 (5) (2023)
Lembris L Njotto, Johanna Simin, Romina Fornes, Ingvild Odsbu, Isabelle Mussche, Steven Callens, Lars Engstrand, Robin Bruyndonckx, Nele Brusselaers
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. Drug safety 46 (5) (2023)
Lembris L Njotto, Johanna Simin, Romina Fornes, Ingvild Odsbu, Isabelle Mussche, Steven Callens, Lars Engstrand, Robin Bruyndonckx, Nele Brusselaers
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. Drug safety 46 (5) (2023)
Katarina Kralova, Carol-Ann Wilson, Nicolas Richebourg, Joan D'souza
Quality of MedDRA ® Coding in a Sample of COVID-19 Vaccine Medication Error Data. Drug safety 46 (5) (2023)
Lembris L Njotto, Johanna Simin, Romina Fornes, Ingvild Odsbu, Isabelle Mussche, Steven Callens, Lars Engstrand, Robin Bruyndonckx, Nele Brusselaers
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. Drug safety 46 (5) (2023)
Lembris L Njotto, Johanna Simin, Romina Fornes, Ingvild Odsbu, Isabelle Mussche, Steven Callens, Lars Engstrand, Robin Bruyndonckx, Nele Brusselaers
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. Drug safety 46 (5) (2023)
Katarina Kralova, Carol-Ann Wilson, Nicolas Richebourg, Joan D'souza
Quality of MedDRA ® Coding in a Sample of COVID-19 Vaccine Medication Error Data. Drug safety 46 (5) (2023)